Details for: TAP1
Gene ID: 6890
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: TAP1
Ensembl ID: ENSG00000168394
Description: transporter 1, ATP binding cassette subfamily B member
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 15.42rCSI 30.56%PRS 76.65
-
CSI 13.52rCSI 10.63%PRS 69.98
-
CSI 11.66rCSI 18.69%PRS 83.54
-
CSI 11.12rCSI 7.76%PRS 66.04
-
CSI 8.45rCSI 5.63%PRS 82.32
-
CSI 8.06rCSI 6.02%PRS 79.59
-
CSI 7.98rCSI 7.21%PRS 60.22
-
CSI 7.14rCSI 5.96%PRS 73.23
-
CSI 6.84rCSI 14.13%PRS 64.53
-
CSI 6.79rCSI 22.03%PRS 63.33
-
CSI 6.63rCSI 7.94%PRS 79.4
-
CSI 6.03rCSI 5.7%PRS 62.72
-
CSI 5.97rCSI 7.44%PRS 74.29
-
CSI 5.87rCSI 7.51%PRS 83.41
-
CSI 5.62rCSI 6.32%PRS 79.55
-
CSI 5.32rCSI 3.53%PRS 66.37
-
CSI 5.16rCSI 7.02%PRS 74.96
-
CSI 4.99rCSI 4.54%PRS 77.8
-
CSI 4.96rCSI 3.71%PRS 78.5
-
CSI 4.96rCSI 7.62%PRS 72.31
-
CSI 4.73rCSI 4.11%PRS 74
-
CSI 4.69rCSI 6.49%PRS 64.03
-
CSI 4.68rCSI 10.62%PRS 66.79
-
CSI 4.55rCSI 10.17%PRS 71.17
-
CSI 4.54rCSI 25.42%PRS 69.83
-
CSI 4.43rCSI 3.18%PRS 77.48
-
CSI 4.32rCSI 5.89%PRS 86.86
-
CSI 4.16rCSI 12.41%PRS 79.95
-
CSI 4.1rCSI 3.44%PRS 67.6
-
CSI 4.04rCSI 3.74%PRS 82.37
-
CSI 3.94rCSI 14.25%PRS 82.56
-
CSI 3.93rCSI 11.38%PRS 64.51
-
CSI 3.91rCSI 3.86%PRS 85.37
-
CSI 3.9rCSI 5.7%PRS 68.19
-
CSI 3.83rCSI 4.1%PRS 62.98
-
CSI 3.82rCSI 2.57%PRS 76.49
-
CSI 3.54rCSI 5.34%PRS 67.64
-
CSI 3.22rCSI 2.41%PRS 88.25
-
CSI 3.16rCSI 2.53%PRS 82.91
-
CSI 3.13rCSI 2.63%PRS 80.02
-
CSI 3rCSI 3.13%PRS 63.58
-
CSI 2.92rCSI 2.05%PRS 81.38
-
CSI 2.91rCSI 6.41%PRS 67.63
-
CSI 2.86rCSI 3.52%PRS 76.4
-
CSI 2.84rCSI 5.14%PRS 76.6
-
CSI 2.84rCSI 1.97%PRS 74.51
-
CSI 2.77rCSI 2.58%PRS 63.89
-
CSI 2.7rCSI 2.6%PRS 63.22
-
CSI 2.66rCSI 5.52%PRS 60.35
-
CSI 2.65rCSI 2.01%PRS 76.36
-
CSI 2.64rCSI 2.8%PRS 73.27
-
CSI 2.61rCSI 2.6%PRS 56.56
-
CSI 2.52rCSI 5.87%PRS 80.53
-
CSI 2.47rCSI 3%PRS 70.81
-
CSI 2.41rCSI 4.56%PRS 81.06
-
CSI 2.39rCSI 4.56%PRS 77.78
-
CSI 2.37rCSI 2.47%PRS 84.48
-
CSI 2.34rCSI 2.05%PRS 72.62
-
CSI 2.33rCSI 1.93%PRS 62.61
-
CSI 2.25rCSI 2.08%PRS 64.76
-
CSI 2.23rCSI 2.61%PRS 79.63
-
CSI 2.22rCSI 3.83%PRS 53.25
-
CSI 2.22rCSI 2.25%PRS 87.56
-
CSI 2.18rCSI 1.52%PRS 78.52
-
CSI 2.18rCSI 1.76%PRS 64.75
-
CSI 2.15rCSI 1.27%PRS 80.57
-
CSI 2.13rCSI 2.46%PRS 73.41
-
CSI 2.12rCSI 2.17%PRS 77.21
-
CSI 2.12rCSI 1.75%PRS 65.56
-
CSI 2.09rCSI 3.26%PRS 86.02
-
CSI 2.07rCSI 11.14%PRS 75.28
-
CSI 2.06rCSI 1.99%PRS 53.98
-
CSI 2.01rCSI 2.36%PRS 65.5
-
CSI 1.99rCSI 2.4%PRS 72.29
-
CSI 1.93rCSI 2.64%PRS 69.31
-
CSI 1.88rCSI 5.38%PRS 82.8
-
CSI 1.85rCSI 2.29%PRS 59.98
-
CSI 1.84rCSI 3.73%PRS 42.39
-
CSI 1.83rCSI 1.42%PRS 80.84
-
CSI 1.82rCSI 4.98%PRS 80.14
-
CSI 1.81rCSI 1.78%PRS 78.89
-
CSI 1.81rCSI 2.49%PRS 82.29
-
CSI 1.79rCSI 1.76%PRS 83.92
-
CSI 1.76rCSI 2.03%PRS 53.45
-
CSI 1.71rCSI 1.52%PRS 61.19
-
CSI 1.69rCSI 1.72%PRS 75.8
-
CSI 1.67rCSI 2.71%PRS 59.81
-
CSI 1.64rCSI 1.3%PRS 84.11
-
CSI 1.63rCSI 1.24%PRS 77.23
-
CSI 1.62rCSI 2.47%PRS 67.48
-
CSI 1.61rCSI 2.59%PRS 66.75
-
CSI 1.6rCSI 1.23%PRS 63.9
-
CSI 1.59rCSI 1.18%PRS 76.67
-
CSI 1.59rCSI 2.29%PRS 73.75
-
CSI 1.54rCSI 2.8%PRS 54.9
-
CSI 1.53rCSI 1.61%PRS 59.69
-
CSI 1.53rCSI 1.83%PRS 82.43
-
CSI 1.5rCSI 1.96%PRS 76.75
-
CSI 1.48rCSI 1.86%PRS 75.33
-
CSI 1.38rCSI 3.99%PRS 75.16
-
CSI 0.4rCSI 2.0%PRS 72.3%
-
CSI 0.4rCSI 1.9%PRS 75.8%
-
CSI 0.4rCSI 1.9%PRS 75.2%
-
CSI 0.5rCSI 2.6%PRS 61.7%
-
CSI 0.5rCSI 3.1%PRS 75.8%
-
CSI 0.5rCSI 2.3%PRS 90.6%
-
CSI 0.6rCSI 3.4%PRS 81.5%
-
CSI 0.6rCSI 2.2%PRS 71.6%
-
CSI 0.7rCSI 1.9%PRS 74.4%
-
CSI 0.7rCSI 16.5%PRS 80.2%
-
CSI 0.7rCSI 5.7%PRS 56.4%
-
CSI 0.7rCSI 1.7%PRS 72.0%
-
CSI 0.7rCSI 13.8%PRS 90.5%
-
CSI 0.8rCSI 1.5%PRS 88.1%
-
CSI 0.8rCSI 15.2%PRS 78.2%
-
CSI 0.8rCSI 1.0%PRS 49.7%
-
CSI 0.8rCSI 1.7%PRS 74.1%
-
CSI 0.8rCSI 1.1%PRS 69.8%
-
CSI 0.8rCSI 1.1%PRS 33.3%
-
CSI 0.8rCSI 3.7%PRS 77.5%
-
CSI 0.9rCSI 3.0%PRS 75.8%
-
CSI 0.9rCSI 1.6%PRS 90.3%
-
CSI 0.9rCSI 2.9%PRS 87.2%
-
CSI 0.9rCSI 1.1%PRS 73.7%
-
CSI 0.9rCSI 15.6%PRS 84.1%
-
CSI 1.0rCSI 2.3%PRS 66.8%
-
CSI 1.1rCSI 2.1%PRS 66.3%
-
CSI 1.1rCSI 1.6%PRS 79.1%
-
CSI 1.2rCSI 1.6%PRS 68.0%
-
CSI 1.2rCSI 5.2%PRS 79.3%
-
CSI 1.2rCSI 1.7%PRS 66.7%
-
CSI 1.2rCSI 1.9%PRS 67.4%
-
CSI 1.2rCSI 1.8%PRS 78.8%
-
CSI 1.2rCSI 6.7%PRS 85.1%
-
CSI 1.3rCSI 0.9%PRS 68.9%
-
CSI 1.3rCSI 1.9%PRS 72.6%
-
CSI 1.3rCSI 1.2%PRS 83.9%
-
CSI 1.3rCSI 2.8%PRS 76.5%
-
CSI 1.3rCSI 1.8%PRS 63.6%
-
CSI 1.4rCSI 4.0%PRS 75.2%
-
CSI 1.5rCSI 1.9%PRS 75.3%
-
CSI 1.5rCSI 2.0%PRS 76.8%
-
CSI 1.5rCSI 1.8%PRS 82.4%
-
CSI 1.5rCSI 1.6%PRS 59.7%
-
CSI 1.5rCSI 2.8%PRS 54.9%
-
CSI 1.6rCSI 2.3%PRS 73.8%
-
CSI 1.6rCSI 1.2%PRS 76.7%
-
CSI 1.6rCSI 1.2%PRS 63.9%
-
CSI 1.6rCSI 2.6%PRS 66.8%
-
CSI 1.6rCSI 2.5%PRS 67.5%
-
CSI 1.6rCSI 1.2%PRS 77.2%
-
CSI 1.6rCSI 1.3%PRS 84.1%
-
CSI 1.7rCSI 2.7%PRS 59.8%
-
CSI 1.7rCSI 1.7%PRS 75.8%
-
CSI 1.7rCSI 1.5%PRS 61.2%
-
CSI 1.8rCSI 2.0%PRS 53.5%
-
CSI 1.8rCSI 1.8%PRS 83.9%
-
CSI 1.8rCSI 2.5%PRS 82.3%
-
CSI 1.8rCSI 1.8%PRS 78.9%
-
CSI 1.8rCSI 5.0%PRS 80.1%
-
CSI 1.8rCSI 1.4%PRS 80.8%
-
CSI 1.8rCSI 3.7%PRS 42.4%
-
CSI 1.9rCSI 2.3%PRS 60.0%
-
CSI 1.9rCSI 5.4%PRS 82.8%
-
CSI 1.9rCSI 2.6%PRS 69.3%
-
CSI 2.0rCSI 2.4%PRS 72.3%
-
CSI 2.0rCSI 2.4%PRS 65.5%
-
CSI 2.1rCSI 2.0%PRS 54.0%
-
CSI 2.1rCSI 11.1%PRS 75.3%
-
CSI 2.1rCSI 3.3%PRS 86.0%
-
CSI 2.1rCSI 1.8%PRS 65.6%
-
CSI 2.1rCSI 2.2%PRS 77.2%
-
CSI 2.1rCSI 2.5%PRS 73.4%
-
CSI 2.2rCSI 1.3%PRS 80.6%
-
CSI 2.2rCSI 1.8%PRS 64.8%
-
CSI 2.2rCSI 1.5%PRS 78.5%
-
CSI 2.2rCSI 2.3%PRS 87.6%
-
CSI 2.2rCSI 3.8%PRS 53.3%
-
CSI 2.2rCSI 2.6%PRS 79.6%
-
CSI 2.3rCSI 2.1%PRS 64.8%
-
CSI 2.3rCSI 1.9%PRS 62.6%
-
CSI 2.3rCSI 2.1%PRS 72.6%
-
CSI 2.4rCSI 2.5%PRS 84.5%
-
CSI 2.4rCSI 4.6%PRS 77.8%
-
CSI 2.4rCSI 4.6%PRS 81.1%
-
CSI 2.5rCSI 3.0%PRS 70.8%
-
CSI 2.5rCSI 5.9%PRS 80.5%
-
CSI 2.6rCSI 2.6%PRS 56.6%
-
CSI 2.6rCSI 2.8%PRS 73.3%
-
CSI 2.7rCSI 2.0%PRS 76.4%
-
CSI 2.7rCSI 5.5%PRS 60.4%
-
CSI 2.7rCSI 2.6%PRS 63.2%
-
CSI 2.8rCSI 2.6%PRS 63.9%
-
CSI 2.8rCSI 2.0%PRS 74.5%
-
CSI 2.8rCSI 5.1%PRS 76.6%
-
CSI 2.9rCSI 3.5%PRS 76.4%
-
CSI 2.9rCSI 6.4%PRS 67.6%
-
CSI 2.9rCSI 2.1%PRS 81.4%
-
CSI 3.0rCSI 3.1%PRS 63.6%
-
CSI 3.1rCSI 2.6%PRS 80.0%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3734975917
Symbol: TAP1_HUMAN
Name: Antigen peptide transporter 1
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 2259383
Title: Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters.
PubMed ID: 2259383
DOI: 10.1038/348741a0
PubMed ID: 1453454
Title: DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing.
PubMed ID: 1453454
PubMed ID: 8568858
Title: Evolutionary dynamics of non-coding sequences within the class II region of the human MHC.
PubMed ID: 8568858
PubMed ID: 14574404
Title: The DNA sequence and analysis of human chromosome 6.
PubMed ID: 14574404
DOI: 10.1038/nature02055
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 8248212
Title: TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility.
PubMed ID: 8248212
PubMed ID: 2259384
Title: A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway.
PubMed ID: 2259384
DOI: 10.1038/348744a0
PubMed ID: 8168860
PubMed ID: 1946428
Title: Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region.
PubMed ID: 1946428
PubMed ID: 1589036
Title: Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi.
PubMed ID: 1589036
DOI: 10.1038/357342a0
PubMed ID: 1538751
Title: Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex.
PubMed ID: 1538751
DOI: 10.1038/355641a0
PubMed ID: 7500034
Title: The peptide-binding motif for the human transporter associated with antigen processing.
PubMed ID: 7500034
PubMed ID: 7760936
Title: A viral inhibitor of peptide transporters for antigen presentation.
PubMed ID: 7760936
DOI: 10.1038/375415a0
PubMed ID: 8805302
Title: Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
PubMed ID: 8805302
PubMed ID: 8670825
Title: Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.
PubMed ID: 8670825
PubMed ID: 8630735
Title: A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL.
PubMed ID: 8630735
PubMed ID: 8955196
Title: Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site.
PubMed ID: 8955196
PubMed ID: 9310490
Title: Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.
PubMed ID: 9310490
PubMed ID: 9175839
Title: The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.
PubMed ID: 9175839
PubMed ID: 9256420
Title: Recognition principle of the TAP transporter disclosed by combinatorial peptide libraries.
PubMed ID: 9256420
PubMed ID: 9427624
Title: TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
PubMed ID: 9427624
PubMed ID: 10227971
Title: Adenovirus E19 has two mechanisms for affecting class I MHC expression.
PubMed ID: 10227971
PubMed ID: 10605026
Title: HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.
PubMed ID: 10605026
PubMed ID: 11157746
Title: The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.
PubMed ID: 11157746
PubMed ID: 11274390
Title: Allosteric crosstalk between peptide-binding, transport, and ATP hydrolysis of the ABC transporter TAP.
PubMed ID: 11274390
PubMed ID: 15488952
Title: Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome.
PubMed ID: 15488952
PubMed ID: 19201886
Title: Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation.
PubMed ID: 19201886
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 22638925
Title: Direct evidence that the N-terminal extensions of the TAP complex act as autonomous interaction scaffolds for the assembly of the MHC I peptide-loading complex.
PubMed ID: 22638925
PubMed ID: 25377891
Title: Mechanistic determinants of the directionality and energetics of active export by a heterodimeric ABC transporter.
PubMed ID: 25377891
DOI: 10.1038/ncomms6419
PubMed ID: 25656091
Title: Ultrasensitive quantification of TAP-dependent antigen compartmentalization in scarce primary immune cell subsets.
PubMed ID: 25656091
DOI: 10.1038/ncomms7199
PubMed ID: 25944712
Title: N-terminome analysis of the human mitochondrial proteome.
PubMed ID: 25944712
PubMed ID: 26611325
Title: Assembly of the MHC I peptide-loading complex determined by a conserved ionic lock-switch.
PubMed ID: 26611325
DOI: 10.1038/srep17341
PubMed ID: 11532960
Title: Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing.
PubMed ID: 11532960
PubMed ID: 1570316
Title: Allelic variants of the human putative peptide transporter involved in antigen processing.
PubMed ID: 1570316
PubMed ID: 8640228
Title: A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer.
PubMed ID: 8640228
DOI: 10.1038/ng0696-210
PubMed ID: 10074494
Title: Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome.
PubMed ID: 10074494
DOI: 10.1172/jci5335
PubMed ID: 11250043
Title: TAP1 polymorphisms in several human ethnic groups: characteristics, evolution, and genotyping strategies.
PubMed ID: 11250043
PubMed ID: 12878362
Title: Novel TAP1 polymorphisms in indigenous Zimbabweans: their potential implications on TAP function and in human diseases.
PubMed ID: 12878362
Sequence Information:
- Length: 748
- Mass: 80965
- Checksum: E703ECCC09417002
- Sequence:
MASSRCPAPR GCRCLPGASL AWLGTVLLLL ADWVLLRTAL PRIFSLLVPT ALPLLRVWAV GLSRWAVLWL GACGVLRATV GSKSENAGAQ GWLAALKPLA AALGLALPGL ALFRELISWG APGSADSTRL LHWGSHPTAF VVSYAAALPA AALWHKLGSL WVPGGQGGSG NPVRRLLGCL GSETRRLSLF LVLVVLSSLG EMAIPFFTGR LTDWILQDGS ADTFTRNLTL MSILTIASAV LEFVGDGIYN NTMGHVHSHL QGEVFGAVLR QETEFFQQNQ TGNIMSRVTE DTSTLSDSLS ENLSLFLWYL VRGLCLLGIM LWGSVSLTMV TLITLPLLFL LPKKVGKWYQ LLEVQVRESL AKSSQVAIEA LSAMPTVRSF ANEEGEAQKF REKLQEIKTL NQKEAVAYAV NSWTTSISGM LLKVGILYIG GQLVTSGAVS SGNLVTFVLY QMQFTQAVEV LLSIYPRVQK AVGSSEKIFE YLDRTPRCPP SGLLTPLHLE GLVQFQDVSF AYPNRPDVLV LQGLTFTLRP GEVTALVGPN GSGKSTVAAL LQNLYQPTGG QLLLDGKPLP QYEHRYLHRQ VAAVGQEPQV FGRSLQENIA YGLTQKPTME EITAAAVKSG AHSFISGLPQ GYDTEVDEAG SQLSGGQRQA VALARALIRK PCVLILDDAT SALDANSQLQ VEQLLYESPE RYSRSVLLIT QHLSLVEQAD HILFLEGGAI REGGTHQQLM EKKGCYWAMV QAPADAPE
Genular Protein ID: 1422620871
Symbol: B7Z7P4_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Sequence Information:
- Length: 547
- Mass: 59940
- Checksum: 0DC4A144CA6D6D6A
- Sequence:
MAIPFFTGRL TDWILQDGSA DTFTRNLTLM SILTIASAVL EFVGDGIYNN TMGHVHSHLQ GEVFGAVLRQ ETEFFQQNQT GNIMSRVTED TSTLSDSLSE NLSLFLWYLV RGLCLLGIML WGSVSLTMVT LITLPLLFLL PKKVGKWYQL LEVQVRESLA KSSQVAIEAL SAMPTVRSFA NEEGEAQKFR EKLQEIKTLN QKEAVAYAVN SWTTSISGML LKVGILYIGG QLVTSGAVSS GNLVTFVLCQ MQFTQAVEVL LSIYPRVQKA VGSSEKIFEY LDRTPRCPPS GLLTPLHLEG LVQFQDVSFA YPNRPDVLVL QGLTFTLRPG EVTALVGPNG SGKSTVAALL QNLYQPTGGQ LLLDGKPLPQ YEHRYLHRQV AAVGQEPQVF GRSLQENIAY GLTQKPTMEE ITAAAVKSGA HSFISGLPQG YDTEVDEAGS QLSGGQRQAV ALARALIRKP CVLILDDATS ALDANSQLQV EQLLYESPER YSRSVLLITQ HLSLVEQADH ILFLEGGAIR EGGTHQQLME KKGCYWAMVQ APADAPE
Genular Protein ID: 2201774261
Symbol: A0A0S2Z5A6_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 26871637
Title: Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.
PubMed ID: 26871637
Sequence Information:
- Length: 808
- Mass: 87218
- Checksum: 9CA5FF96FADD6A1B
- Sequence:
MAELLASAGS ACSWDFPRAP PSFPPPAASR GGLGGTRSFR PHRGAESPRP GRDRDGVRVP MASSRCPAPR GCRCLPGASL AWLGTVLLLL ADWVLLRTAL PRIFSLLVPT ALPLLRVWAV GLSRWAVLWL GACGVLRATV GSKSENAGAQ GWLAALKPLA AALGLALPGL ALFRELISWG APGSADSTRL LHWGSHPTAF VVSYAAALPA AALWHKLGSL WVPGGQGGSG NPVRRLLGCL GSETRRLSLF LVLVVLSSLG EMAIPFFTGR LTDWILQDGS ADTFTRNLTL MSILTIASAV LEFVGDGIYN NTMGHVHSHL QGEVFGAVLR QETEFFQQNQ TGNIMSRVTE DTSTLSDSLS ENLSLFLWYL VRGLCLLGIM LWGSVSLTMV TLITLPLLFL LPKKVGKWYQ LLEVQVRESL AKSSQVAIEA LSAMPTVRSF ANEEGEAQKF REKLQEIKTL NQKEAVAYAV NSWTTSISGM LLKVGILYIG GQLVTSGAVS SGNLVTFVLY QMQFTQAVEV LLSIYPRVQK AVGSSEKIFE YLDRTPRCPP SGLLTPLHLE GLVQFQDVSF AYPNRPDVLV LQGLTFTLRP GEVTALVGPN GSGKSTVAAL LQNLYQPTGG QLLLDGKPLP QYEHRYLHRQ VAAVGQEPQV FGRSLQENIA YGLTQKPTME EITAAAVKSG AHSFISGLPQ GYDTEVDEAG SQLSGGQRQA VALARALIRK PCVLILDDAT SALDANSQLQ VEQLLYESPE RYSRSVLLIT QHLSLVEQAD HILFLEGGAI REGGTHQQLM EKKGCYWAMV QAPADAPE